Mejia, Miecel C.

HRN: 23-78-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFUROXIME 500MG (TAB)
09/29/2023
10/06/2023
PO
500mg
BID X 7 Days
S/P NSVD To A Stillborn
Checking Final Appropriateness 
09/29/2023
CEFUROXIME 1.5GM (VIAL)
09/29/2023
09/30/2023
IV
1.5g
Q8
S/P NSVD To Stillborn; CAP
Checking Final Appropriateness 
09/29/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/29/2023
10/06/2023
IV INFUSION
4.5
Q8hr
Sepsis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: